Quick Start Durvalumab Following Chemoradiation for Stage III Nonsmall Cell Lung Cancer

Clinical trial NCT05696782 · RECRUITING

Trial details

NCT number: NCT05696782
Sponsor: Wake Forest University Health Sciences
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Nonsmall Cell Lung Cancer Stage III Unresectable Non-Small Cell Lung Carcinoma Nonsmall Cell Lung Cancer, Stage II

Start date: 2023-07-26
Primary completion: 2027-02-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.